HK$4.80
8.22%
Hong Kong, Nov 20, 04:08 pm HKT. Closed.
ISIN
KYG7S12M1051
Symbol
2228

Xtalpi Holdings Stock price

HK$5.23
-0.69 11.66% 1M
-2.95 36.06% 6M
-4.23 44.71% YTD
-4.92 48.47% 1Y
-0.57 9.83% 3Y
-0.57 9.83% 5Y
-0.57 9.83% 10Y
-0.57 9.83% 20Y
Hong Kong, Closing price Thu, Nov 19 2026
-0.16 2.97%

AI Insights on Xtalpi Holdings Insights AI Insights on Xtalpi Holdings

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Is Xtalpi Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$23.1b
Enterprise Value
HK$16.6b
Net debt
positive
Cash
HK$10.2b
Shares outstanding
4.3b
Valuation
P/E
negative
P/S | estimate
29.0 | 19.1
EV/Sales | estimate
20.9 | 13.7
EV/FCF | ex SBC
negative | negative
P/B
2.2
Financial Health
Equity Ratio
91.8%
Return on Equity
1.3%
ROCE
-8.8%
ROIC
-23.0%
Debt/Equity
0.3
Share-Based Compensation & Dilution
SBC | % of Revenue
HK$145.6m | 18.3%
SBC as % of FCF
-
SBC Growth 1Y
0.2%
Share Count Growth 1Y
7.1%
Shareholder Yield
-7.1%
Financials
Revenue | estimate
HK$797.4m | HK$1.2b
EBITDA
-
EBIT
HK$-982.0m
Net Income
HK$-247.7m
Free Cash Flow | ex SBC
HK$-511.3m | HK$-657.0m
Growth
Revenue | estimate
-0.3% | 28.5%
EBITDA
-
EBIT
-150.7%
Net Income
-7.2%
Free Cash Flow
9.7%
Margin
Gross
51.5%
EBITDA
-
EBIT
-123.1%
Net
-31.1%
Free Cash Flow | ex SBC
-64.1% | -82.4%
More
EPS
HK$-0.1
FCF per Share
HK$-0.1
Short interest
-
Employees
1k
Rev per Employee
HK$750.0k

Xtalpi Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Xtalpi Holdings forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a Xtalpi Holdings forecast:

Buy
82%
Hold
18%

Financial data from Xtalpi Holdings

Jun '26
+/-
%
797 797
0% 0%
100%
- Direct Costs 387 387
302% 302%
48%
411 411
20% 20%
52%
- Selling and Administrative Expenses 599 599
11% 11%
75%
- Research and Development Expense 840 840
67% 67%
105%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -982 -982
151% 151%
-123%
Net Profit -248 -248
7% 7%
-31%

In millions HKD.

Don't miss a Thing! We will send you all news about Xtalpi Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

XtalPi Holdings Ltd. provides drug and material science R&D solutions and services to global conglomerates and companies in the pharmaceutical and material science industries. The company is headquartered in Shenzhen, Guangdong and currently employs 1,054 full-time employees. The company went IPO on 2024-06-13. The firm mainly operates two businesses. Drug discovery solutions primarily encompass the development of early-stage lead compounds and investigational new drugs, providing research support for clinical trial initiation. Intelligent robotics solutions primarily include solid-state research and development services and automated chemical synthesis services. The firm conducts its business in the domestic and overseas markets.

Head office Cayman Islands
CEO Mr. Chen
Employees 1,254
Website www.xtalpi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today